TY - JOUR
T1 - Mechanisms of genomic instabilities underlying two common fragile-site-associated Loci, PARK2 and DMD, in germ cell and cancer cell lines
AU - Mitsui, Jun
AU - Takahashi, Yuji
AU - Goto, Jun
AU - Tomiyama, Hiroyuki
AU - Ishikawa, Shunpei
AU - Yoshino, Hiroyo
AU - Minami, Narihiro
AU - Smith, David I.
AU - Lesage, Suzanne
AU - Aburatani, Hiroyuki
AU - Nishino, Ichizo
AU - Brice, Alexis
AU - Hattori, Nobutaka
AU - Tsuji, Shoji
N1 - Funding Information:
We thank the French Parkinson's Disease Genetics Study Group (PDG) and the DNA and cell bank of the CRicm for sample collection and preparation. This work was supported in part by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas, Applied Genomics, the 21st Century COE Program, Integrated Database Project, Center for Integrated Brain Medical Science, and Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PY - 2010/7/9
Y1 - 2010/7/9
N2 - Common fragile sites (CFSs) are specific chromosome regions that exhibit an increased frequency of breaks when cells are exposed to a DNA-replication inhibitor such as aphidicolin. PARK2 and DMD, the causative genes for autosomal-recessive juvenile Parkinsonism and Duchenne and Becker muscular dystrophy, respectively, are two very large genes that are located within aphidicolin-induced CFSs. Gross rearrangements within these two genes are frequently observed as the causative mutations for these diseases, and similar alterations within the large fragile sites that surround these genes are frequently observed in cancer cells. To elucidate the molecular mechanisms underlying this fragility, we performed a custom-designed high-density comparative genomic hybridization analysis to determine the junction sequences of approximately 500 breakpoints in germ cell lines and cancer cell lines involving PARK2 or DMD. The sequence signatures where these breakpoints occur share some similar features both in germ cell lines and in cancer cell lines. Detailed analyses of these structures revealed that microhomologies are predominantly involved in rearrangement processes. Furthermore, breakpoint-clustering regions coincide with the latest-replicating region and with large nuclear-lamina-associated domains and are flanked by the highest-flexibility peaks and R/G band boundaries, suggesting that factors affecting replication timing collectively contribute to the vulnerability for rearrangement in both germ cell and somatic cell lines.
AB - Common fragile sites (CFSs) are specific chromosome regions that exhibit an increased frequency of breaks when cells are exposed to a DNA-replication inhibitor such as aphidicolin. PARK2 and DMD, the causative genes for autosomal-recessive juvenile Parkinsonism and Duchenne and Becker muscular dystrophy, respectively, are two very large genes that are located within aphidicolin-induced CFSs. Gross rearrangements within these two genes are frequently observed as the causative mutations for these diseases, and similar alterations within the large fragile sites that surround these genes are frequently observed in cancer cells. To elucidate the molecular mechanisms underlying this fragility, we performed a custom-designed high-density comparative genomic hybridization analysis to determine the junction sequences of approximately 500 breakpoints in germ cell lines and cancer cell lines involving PARK2 or DMD. The sequence signatures where these breakpoints occur share some similar features both in germ cell lines and in cancer cell lines. Detailed analyses of these structures revealed that microhomologies are predominantly involved in rearrangement processes. Furthermore, breakpoint-clustering regions coincide with the latest-replicating region and with large nuclear-lamina-associated domains and are flanked by the highest-flexibility peaks and R/G band boundaries, suggesting that factors affecting replication timing collectively contribute to the vulnerability for rearrangement in both germ cell and somatic cell lines.
UR - http://www.scopus.com/inward/record.url?scp=77955084425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955084425&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2010.06.006
DO - 10.1016/j.ajhg.2010.06.006
M3 - Article
C2 - 20598272
AN - SCOPUS:77955084425
SN - 0002-9297
VL - 87
SP - 75
EP - 89
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 1
ER -